Remove Medical science Remove Medicine Remove Patients
article thumbnail

CCC Now Offering Subscriptions to the JAMA Network and The New England Journal of Medicine Through RightFind

Copyright Clearance Center

NEJM is pleased to participate in an innovative new service from CCC that aligns with our goal to meet the information needs of researchers for the highest quality studies in medical science,” said Rob McKinney, Director, NEJM Group Licensing. NEJM is recognized as the world’s leading medical journal and website.

article thumbnail

Amgen and Pfizer appoint new Science executives

European Pharmaceutical Review

In his over 11-year tenure at Pfizer thus far, Dr Boshoff he has delivered 24 approved innovative medicines and biosimilars in over 30 indications, according to Pfizer. “Dr Academy of Medical Sciences. “I The post Amgen and Pfizer appoint new Science executives appeared first on European Pharmaceutical Review.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Artificial Intelligence and Life Expectancy: How AI Will Contribute to Improving Human Health.

MaBiCo

AI applications in medicine, pharmaceuticals, and biology promise to bring about radical changes, making treatments more effective, personalized, and affordable. Personalized Medicine Thanks to AI, we will create simulations of the human body at the molecular, cellular and organ levels, allowing treatments to be personalized for each patient.

article thumbnail

Why R&D innovation holds the key to greater patient impact

European Pharmaceutical Review

3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. However, access to these medicines is not close to meeting patient demand, creating inequalities in the health prospects of those diagnosed with cancer.

Patients 105
article thumbnail

Life sciences response to 2024 Autumn Budget

European Pharmaceutical Review

It pledges to benefit key industry sectors across life sciences including R&D, innovation, manufacturing and medicine. Therefore, to safeguard future economic growth, “the opportunity is now” for science, medicine and R&D sectors to take advantage of what the Autumn Budget has to offer, signals Todd.

article thumbnail

The Role of Medical Science Liaisons in The Pharmaceutical Industry

Contrarian Sales Techniques

Are you ready to explore the fascinating world of Medical Science Liaisons (MSLs) in the pharmaceutical industry ? MSLs are considered the experts in scientific and medical information and they are responsible for building relationships with healthcare professionals. The growing demand for MSLs shows no signs of slowing down.

article thumbnail

Precision Medicine Requires Opportunities to Connect with Patients

PM360

With the development of new technology platforms at breakneck speed, companies are positioning themselves to one day deliver game-changing solutions to patients in their niche—solutions they may have been waiting for all their life. At what point in the patient journey are you most likely to discover the answers you were looking for?